Pharma Industry News

Crypto for CRISPR, a new RNAi startup, & a Nobel for AI

How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech bros getting involved with a controversial CRISPR scientist? And who would you rather hang out with at the STAT Summit next week, Adam or Allison?

We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. First, biotech veteran John Maraganore calls in to discuss his new startup, City Therapeutics, this week’s Nobel Prize awards, and the nerdy accolade he just received.
Read the rest…

How does John Maraganore decide which startups to get involved in? Why are longevity-minded tech bros getting involved with a controversial CRISPR scientist? And who would you rather hang out with at the STAT Summit next week, Adam or Allison?

We discuss all that and more on this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. First, biotech veteran John Maraganore calls in to discuss his new startup, City Therapeutics, this week’s Nobel Prize awards, and the nerdy accolade he just received.

Read the rest…

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]